Levosimendan: a cardiovascular drug to prevent liver ischemia-reperfusion injury?

PLoS One · 2013 · PMC3770697 · PMID 24040056

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

In consistent with the above, our results showed that levosimendan pretreatment applied 1 or 24 hours prior to surgery resulted in highly significant improvement in liver microcirculation compared with the corresponding IR groups.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.